Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Oct 31, 2023 2:50pm
82 Views
Post# 35709760

RE:RE:RE:Interesting read ..........

RE:RE:RE:Interesting read ..........Could be as a Swiss pharma outfit they are not targetting the US for distribution, and therefore wouldnt require it.   With Europe requiring doctors perscriptions for cbd "medicine", they would do very well in that market. 

I really think the countries that are mandating CBD medicines as doctor prescribed only, are the markets that need to be high on Medipharms list, as I was talking to a doctor in Canada recently about CBD getting more mainstream from a physicians perspective, and he said the government bureaucratic red tape is not worth the hassle.

Also, he mentioned "why would I want to get involved in prescribing any type of cbd / thc medicine, when that guy sitting right there could walk across the street to the weed depot, and buy the exact same thing I just perscribed without any controls in place to stop how much he self regulates, etc.  And he can get it in far to many applications. Oil, capsule, lotion, vape, gummies, etc all with varying levels of cbd / thc.  The liability is just too great."

Can you imagine asking your doctor if you could have your precribed heart pain meds in a grape gummy bear, or vape....... lol


i call BS on that the doctors had no problem prescribing the OXY and still prescribe multiudes of uppers downers pain meds etc that they have no controll over how their patients administer or self regulate ...with no liability on their part so why would CBD?THC be any different??????

and to be honest they are not addictive like that other stuff is.

so ya BS on his statement


<< Previous
Bullboard Posts
Next >>